[Elsevier] Tinengotinib for adults with advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 trial |
Reward10points
|
post
reply
points
50
10
Cervical cancer: TGF汕 signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives
10
Cervical cancer: TGF汕 signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives
30
Posicionamiento SEMERGEN en el manejo del paciente oncol車gico: abordaje integral de la cardiotoxicidad en Atenci車n Primaria
20
[Single chapter]6 - Nano-based textile dyeing and printing in fashion and apparel
10
Tinengotinib for adults with advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 trial
